Question · asked by 1 review
CHLORPROMAZINE vs placebo: Leaving the study early
- Population
- patients with schizophrenia
- Intervention
- CHLORPROMAZINE
- Comparison
- placebo
- Outcome
- Leaving the study early
CHLORPROMAZINE may leads to lower leaving the study early compared with PLACEBO (low certainty).
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
CHLORPROMAZINE vs PLACEBO Leaving the study early · patients with schizophrenia CHLORPROMAZINE may leads to lower leaving the study early compared with PLACEBO (low certainty). Chlorpromazine versus placebo for schizophrenia (2014) · Cochrane Headline outcomes only | RR 0.64 [0.53, 0.78] | 27 studies · 1831 participants | Low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Chlorpromazine versus placebo for schizophrenia 2014 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- CHLORPROMAZINE vs Clotiapine · patients with schizophrenia · 1 review
- CHLORPROMAZINE vs haloperidol · patients with psychosis‐induced aggression or agitation · 1 review
- CHLORPROMAZINE vs piperacetazine · patients with schizophrenia · 1 review
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.